The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Vical Inc.  (VICL) Trade Now »     Rate VICL  -  Discuss VICL  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
58.0%
Top:
100.0%
Rate VICL:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

VICL: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

phase 2 anyone Graphic_rating_buy VICL
79%
 +46.51%
in 270 days
operating losses are large, classic pharma bet on probability of phase 2 outcome relative to cash burn.
By  gog   (-38.36%  risk: moderate)  02/14/09 Comment




From the Blogosphere

Three Core Biotech Holdings: Isis, Ligand and Vical

Isis (ISIS), Ligand (LGND) and Vical (VICL) have been my core biotech holdings since the mid 1990s and I have been steadily adding to these positions each time the market has lost faith. They share common themes and some differences. Isis and Vical have maintained consistent management throughout the years, whereas Ligand radically changed direction a few years ago when Daniel Loeb’s Third Point hedge fund took a stake. Now all three are focused on drug discovery; leaving the marketing to others.

<>All three have many pharmaceutical partnerships and many shots on goal, so one failure would n...
By  trackseekingalpha   (-13.69%  risk: aggressive)  11/09/09 Comment


Vical soars after winning U.S. patent for flu vaccines

Filed under: Good news, Products and services

Vical Inc. (NASDAQ: VICL) surged higher out of the gate Thursday after scoring a U.S. patent for its pandemic and seasonal influenza vaccines, including those to shield against H1N1 (swine flu) and H5N1 (avian flu). Both treatments use Vical's patented Vaxfectin adjuvant, which helps to boost immunity.

<>While the H5N1 vaccine has completed early-stage human trials, the H1N1 vaccine has yet to be tested on human subjects. Positive results have been recorded from tests conducted on mice and rabbits, but VICL said earlier this year that it will requir...
By  Elizabeth Harrow   (+26.50%  risk: conservative)  09/03/09 Comment


What's the Delay In Support for Vical?
<>In the chicken, egg and pig story, what is the delay in the Navy’s support for Vical’s (VICL) DNA based H1N1 swine flu vaccine?

Bloomberg’s “Swine Flu Vaccine Delays Won’t Slow October Timetable” and “First Trials of Swine Flu Vaccine Begin in Australia” report that the US has contracted with five pharmaceutical companies to stockpile swine flu (H1N1) vaccines: Novartis (NVS) 45%, Sanofi Aventis (SNY) 26%, CSL (CSL:AU) 19%, and AstraZeneca (AZN) and GlaxoSmithKline (GSK) the remainder. Of these suppliers, only Australian based CSL is ready to start clinical trials. The other...
By  trackseekingalpha   (-13.69%  risk: aggressive)  07/26/09 Comment


Some Microcap Quick Hits

A few notes from the trading turret:

<>
  • Some of you want to know if I trade any of the stocks coming up on the Century Club scan based on MarketClub’s smart scanner. Sure I do. Last week, for example, I bought Ada-Es (ADES) and Vical (VICL). Both bucked the dismal market and barely stayed green.
  • Highway Holdings (HIHO) is off about thirty cents since the last post, down very close to my entry point. I still like it, especially after HIHO declared a three cent dividend. If that becomes a quarterly event, the yield would be about 9%.
    • <>One of my all-time best shorts was Zix Corp. (ZIXI)...
    By  trackseekingalpha   (-13.69%  risk: aggressive)  07/13/09 Comment


    After-Hours Movers 5/6: Vanda (VNDA) Surges On FDA Approval, Vical (VICL) Up On Navy Swine Flu Deal, Cisco (CSCO) Up on Results
    <>StreetInsider.com After-Hours Movers:

    Vanda Pharmaceuticals, Inc. (Nasdaq: VNDA) 900% HIGHER; Won approval from the FDA for its schizophrenia drug.

    Vical Incorporated (Nasdaq: VICL) 20% HIGHER; entered into a Cooperative Research and Development Agreement with the U.S. Naval Medical Research Center, a biomedical research organization within the U.S. Navy, for the expedited development of a vaccine against the potentially pandemic H1N1 strain of influenza virus. The goal of the collaborative development program is to rapidly advance a Vaxfectin(r)-formulated H1N1 DNA vaccine into clinical te...
    By  Street Insider   (+14.43%  risk: moderate)  05/06/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.57% 370
    2 Gerald Greene 18.14 +68.57% 207
    3 stockmarketfunding.com 17.66 +25.68% 53
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +77.15% 34


    POPULAR STOCKS
    Symbol Company Name Sentiment
    FNM Fannie Mae
    MSFT Microsoft Corp
    BAC Bank of America Corp
    DRYS DryShips Inc.
    DELL Dell Inc
    INTC Intel Corp

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on VICL

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Vical Inc. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch